Benign neoplasm of middle ear and respiratory system

CD2_BENIGN_EAR_RESP_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D14 Cause of death: ICD-10 — D14 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints CD2_BENIGN_EAR_NASAL_SINUS CD2_BENIGN_LARYNX CD2_BENIGN_TRACHEA CD2_BENIGN_BRONCHUS_LUNG CD2_BENIGN_RESPIRATORY_NOS	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasma benignum auris mediae sive systematis respiratorii

NAME	CD2_BENIGN_EAR_RESP_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_EAR_NASAL_SINUS\|CD2_BENIGN_LARYNX\|CD2_BENIGN_TRACHEA\|CD2_BENIGN_BRONCHUS_LUNG\|CD2_BENIGN_RESPIRATORY_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D14
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D14
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of middle ear and respiratory system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3134	1303	1831
Unadjusted period prevalence (%)	0.66	0.44	0.81
Median age at first event (years)	56.26	52.93	58.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2832: Matched controls
28318

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D14.3

ICD-10 Finland

Benign neoplasm: Bronchus and lung

+∞

323.0

315

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

88.0

323.0

428

D14.0

ICD-10 Finland

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

9427.2

323.0

1167

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

13005.0

323.0

907

130

Kela drug reimbursment

Malignant tumour

+∞

262.6

248

UDQ22

NOMESCO Finland

Microlaryngoscopy

69.6

241.1

277

UDH02

NOMESCO Finland

Rhinopharyngoscopy

8.8

235.6

545

743

DHA10

NOMESCO Finland

Biopsy of cavity of nose

80.6

216.8

244

DHB10

NOMESCO Finland

Excision of lesion of internal nose

151.1

211.8

223

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

207.9

197

B97.7

ICD-10 Finland

Papillomavirus as the cause of diseases classified to other chapters

143.8

201.4

213

C61

ICD-10 Finland

Malignant neoplasm of prostate

270.1

198.6

201

UDQ12

NOMESCO Finland

Flexible laryngoscopy

8.5

186.5

436

591

DQA10

NOMESCO Finland

Biopsy of larynx

142.0

175.6

186

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

32.8

162.5

216

WF002

NOMESCO Finland

Radical radiotherapy

160.1

158.2

166

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

148.2

141

ZXC10

NOMESCO Finland

Use of laser

13.7

140.1

250

198

WX408

NOMESCO Finland

General anesthesy, balanced

3.2

136.1

938

3845

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

115.3

122.1

132

H02AB02

ATC

dexamethasone; systemic

18.8

120.7

189

107

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

4.6

119.7

459

1137

116

Kela drug reimbursment

Prostate cancer

+∞

114.3

109

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

77.6

111.3

126

21210

ICD-8 Finland

Benign neoplasm of respiratory system, Larynx

+∞

110.1

105

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

108.0

103

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.9

104.6

374

854

2121A

ICD-9 Finland

Benign neoplasm of respiratory and intrathoracic organs, Larynx

+∞

103.8

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

67.7

101.5

117

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

5.8

101.1

309

589

A04AA02

ATC

granisetron; systemic, transdermal

124.6

100.7

108

XX3DW

NOMESCO Finland

Time consuming IT work

6.2

99.9

285

498

J38.3

ICD-10 Finland

Other diseases of vocal cords

19.6

90.9

140

PJA12

NOMESCO Finland

Sentinel node biopsy

312.0

89.3

2120A

ICD-9 Finland

Benign neoplasm of respiratory and intrathoracic organs, Nasal cavities, middle ear and accessory sinuses

+∞

89.0

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.9

88.7

653

2672

A03FA01

ATC

metoclopramide; systemic, rectal

3.4

87.4

477

1582

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

7.1

85.5

220

332

1420

FHL

Laryngomicroscopy

23.3

83.4

121

WX402

NOMESCO Finland

General anaesthesia

3.2

81.5

497

1782

WF003

NOMESCO Finland

Adjuvant radiotherapy

413.9

81.3

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

168.7

78.5

UDM02

NOMESCO Finland

Sinoscopy

9.2

78.3

170

196

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

7.6

77.3

189

264

115

Kela drug reimbursment

Breast cancer

+∞

75.3

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

18.8

73.2

114

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

+∞

73.2

2123A

ICD-9 Finland

Benign neoplasm of respiratory and intrathoracic organs, Bronchus and lung

+∞

72.2

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

3.4

69.2

376

1229

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

69.0

J37.0

ICD-10 Finland

Chronic laryngitis

6.4

68.8

190

315

UDQ02

NOMESCO Finland

Direct laryngoscopy

20.5

68.3

103

JN4BD

NOMESCO Finland

Extensive body CT

4.6

68.1

255

601

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

58.7

68.1

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

66.9

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.1

66.0

143

164

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

28.3

64.3

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

117.8

64.1

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

63.8

1240

7932

D14.4

ICD-10 Finland

Benign neoplasm: Respiratory system, unspecified

+∞

63.8

ZX090

NOMESCO Finland

Other technic of radiotherapy

116.0

63.1

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.3

63.0

202

402

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

318.7

62.6

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

60.9

783

4198

EP1AE

NOMESCO Finland

Neck ultrasound examination

5.1

59.9

200

417

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

59.6

L02AE02

ATC

leuprorelin; implant, parenteral

24.0

58.6

J33.0

ICD-10 Finland

Polyp of nasal cavity

5.6

57.6

176

331

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.5

57.1

293

910

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

14.0

56.9

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

57.1

56.8

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

56.4

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

558.5

55.8

C30.0

ICD-10 Finland

Malignant neoplasm: Nasal cavity

+∞

55.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

55.4

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

537.7

53.7

UJC01

NOMESCO Finland

Scopy of lower throat

16.3

53.3

L02BB03

ATC

bicalutamide; oral

+∞

51.2

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.4

51.2

198

480

A02BC02

ATC

pantoprazole; systemic

1.8

49.8

1744

13269

H02AB06

ATC

prednisolone; systemic

1.8

49.6

1329

9256

DNB30

NOMESCO Finland

Excision of lesion of ethmoidal sinus

+∞

49.1

Y77

ICPC

Malignant neoplasm prostate

485.7

48.5

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

15.2

47.8

L03AA13

ATC

pegfilgrastim; parenteral

+∞

47.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

45.9

DM1DG

NOMESCO Finland

Paranasal sinuses and face area very extensive MRI examination with high intensity magnet

66.1

45.2

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

+∞

44.9

DHB00

NOMESCO Finland

Excision of lesion of external nose

29.1

44.4

R01AD08

ATC

fluticasone; nasal

1.9

44.2

786

4700

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

228.4

44.0

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

14.2

43.7

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

42.8

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

42.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

42.5

1331

9564

DHB40

NOMESCO Finland

Conchotomy

47.1

42.0

DPA30

NOMESCO Finland

Sphenotomy

16.2

41.8

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.3

41.5

162

396

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.8

40.9

141

304

L01BC06

ATC

capecitabine; oral

+∞

40.7

DMB10

NOMESCO Finland

Radical maxillary antrotomy

23.6

40.6

DHB20

NOMESCO Finland

Polypectomy of internal nose

7.0

40.1

102

151

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

+∞

39.7

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

39.7

A04AA55

ATC

palonosetron, combinations; systemic

+∞

39.7

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

39.7

N02BE01

ATC

paracetamol; systemic, rectal

1.9

39.2

2286

19598

WF004

NOMESCO Finland

Palliative radiotherapy

392.6

39.1

ZXA05

NOMESCO Finland

Left side

1.9

38.8

724

4365

HAC20

NOMESCO Finland

Total mastectomy

138.5

38.8

N02AA05

ATC

oxycodone; systemic

2.4

38.3

346

1528

A04AA01

ATC

ondansetron; systemic, rectal

5.6

38.3

115

212

R01AD09

ATC

mometasone; nasal

1.7

38.0

1144

8036

GDA20

NOMESCO Finland

Excision of lesion of lung

103.9

37.8

A02BC05

ATC

esomeprazole; systemic

1.7

37.6

1087

7533

C32.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of larynx

+∞

37.6

Z51.5

ICD-10 Finland

Palliative care

5.5

37.1

113

212

WX110

NOMESCO Finland

Local anesthesy

1.7

36.9

1734

13766

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

361.6

36.0

DMB30

NOMESCO Finland

Transmaxillary excision of lesion of maxillary antrum

187.3

35.8

J33.8

ICD-10 Finland

Other polyp of sinus

5.0

35.7

118

243

21200

ICD-8 Finland

Benign neoplasm of respiratory system, Cavi nasi

+∞

35.5

DQB30

NOMESCO Finland

Laryngectomy

+∞

35.5

WZC30

NOMESCO Finland

Teaching

2.5

35.5

292

1225

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

67.5

35.0

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.1

34.5

112

226

21202

ICD-8 Finland

Benign neoplasm of respiratory system, Sinus maxillaris

+∞

34.4

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

20.7

34.4

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

10.7

34.4

ZXA00

NOMESCO Finland

Right side

1.8

34.2

741

4666

WX002

NOMESCO Finland

Sedation and analgesia

1.9

34.0

543

3075

DJW00

NOMESCO Finland

Removal of local lesion of nasal septum

341.0

34.0

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

121.4

33.7

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

33.4

B977, D141

ICD-10 Finland

+∞

33.4

21230

ICD-8 Finland

Benign neoplasm of respiratory system, Bronchus and lung

+∞

33.4

JDB10

NOMESCO Finland

Percutaneous gastrostomy

10.5

33.1

N02AX02

ATC

tramadol; systemic, rectal

1.6

33.1

1127

8098

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

35.5

32.8

J01DB01

ATC

cefalexin; oral

1.7

32.7

2140

18266

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

32.6

775

5016

L03AA02

ATC

filgrastim; parenteral

34.6

31.9

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.7

31.8

111

243

4256

FHL

Nasal or sinus tumor removal

166.8

31.7

JN4AD

NOMESCO Finland

Body CT examination

3.7

31.6

143

399

WX734

NOMESCO Finland

JET-ventilation

48.1

31.6

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

36.8

31.5

HAB40

NOMESCO Finland

Wedge excision of mammary gland

14.6

31.4

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

31.4

534

3083

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

31.3

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

5.2

31.2

195

DQE00

NOMESCO Finland

Implantation of prosthetic replacement for larynx

316.1

30.9

ZX080

NOMESCO Finland

Image guided radiotherapy

161.7

30.7

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

13.5

30.4

GD1AD

NOMESCO Finland

Thorax CT examination

3.7

29.9

136

381

J01MA12

ATC

levofloxacin; systemic

1.9

29.1

490

2811

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

34.0

28.7

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.6

28.5

156

B01AB05

ATC

enoxaparin; parenteral

1.7

28.3

706

4599

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

28.2

D14.2

ICD-10 Finland

Benign neoplasm: Trachea

+∞

28.2

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

28.2

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

27.8

346

1762

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

146.4

27.7

J01AA02

ATC

doxycycline; systemic

1.6

27.6

2078

17868

R03AC02

ATC

salbutamol; inhalant

1.6

27.3

1320

10196

C50.99

ICD-10 Finland

Breast, unspecified

+∞

27.1

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

27.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

26.9

859

5977

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

273.4

26.8

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

97.6

26.7

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

9.2

26.7

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

19.3

26.5

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

14.9

26.5

R4110

NOMESCO Finland

Physiotherapy

1.7

26.0

645

4179

UJF32

NOMESCO Finland

Coloscopy

1.7

25.9

650

4224

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

31.2

25.9

JN4CD

NOMESCO Finland

Very extensive body CT

5.6

25.8

138

A04AD12

ATC

aprepitant; systemic

136.2

25.6

HA1AA

NOMESCO Finland

X-ray mammography

4.4

25.5

218

R49.01

ICD-10 Finland

Functional dysphonia

3.9

25.5

108

286

J31.0

ICD-10 Finland

Chronic rhinitis

2.4

25.0

229

1010

R49.0

ICD-10 Finland

Dysphonia

5.1

25.0

160

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

25.0

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

25.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

25.0

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

25.0

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

25.0

DQB70

NOMESCO Finland

Total excision of vocal cord

131.1

24.6

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

131.1

24.6

UDC00

NOMESCO Finland

Ear microscopy

2.4

24.3

214

927

J01DA01

ATC

[U] cefalexin; systemic

1.5

24.2

1626

13375

R03BB04

ATC

tiotropium bromide; inhalant

2.0

24.2

315

1630

R13

ICD-10 Finland

Dysphagia

2.5

24.1

200

837

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

24.0

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

24.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

23.7

416

2409

A07AA02

ATC

nystatin; oral

2.6

23.7

183

739

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

241.8

23.7

R49.08

ICD-10 Finland

Other specified dysphonia

4.7

23.6

180

NK6AN

NOMESCO Finland

Total body bone isotope imaging

17.0

23.5

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

6.5

23.4

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.5

23.2

131

DM1CG

NOMESCO Finland

Paranasal sinuses and face area extensive MRI examination with high intensity magnet

54.4

23.1

L02BA01

ATC

tamoxifen; oral

36.6

23.0

R01AD12

ATC

fluticasone furoate; nasal

1.6

23.0

678

4585

B977, D140

ICD-10 Finland

+∞

22.9

DNB40

NOMESCO Finland

Sublabial rhinotomy

+∞

22.9

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

22.9

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

22.9

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

22.9

247

1179

L02BG04

ATC

letrozole; oral

8.5

22.8

DMB35

NOMESCO Finland

Endoscopic excision of neoplasm or another lesion from maxillary sinus

120.9

22.6

5823

FHL

Lung avobiopsy and wedge resection

120.9

22.6

J33.9

ICD-10 Finland

Nasal polyp, unspecified

6.4

22.6

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.2

22.4

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

10.6

22.3

J01CA04

ATC

amoxicillin; systemic

1.5

22.2

2031

17687

DKW40

NOMESCO Finland

Ligature of artery of internal nose

24.1

22.1

ZXA10

NOMESCO Finland

Bilateral

1.7

21.9

477

2954

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

21.9

2308

20747

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

16.1

21.9

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

63.0

21.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

21.7

699

4824

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

80.7

21.7

L03AA14

ATC

lipegfilgrastim; parenteral

221.5

21.6

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

221.5

21.6

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

115.9

21.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

21.4

543

3514

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.2

21.3

115

370

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

21.0

646

4401

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

5.3

21.0

122

ZX120

NOMESCO Finland

Intravenous

2.3

20.9

199

895

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

20.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

20.8

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

20.8

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

20.8

1143

8896

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

211.4

20.6

UJC02

NOMESCO Finland

Rigid oesophagoscopy

7.3

20.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

20.3

551

3625

A02BC01

ATC

omeprazole; systemic

1.6

20.3

716

5044

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.4

20.2

172

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

19.8

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

19.8

GB3AV

NOMESCO Finland

201.2

19.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

19.5

408

2487

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

19.4

482

3094

J38.2

ICD-10 Finland

Nodules of vocal cords

12.7

19.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

19.2

215

J01FA10

ATC

azithromycin; systemic

1.4

19.2

1334

10821

N07BA03

ATC

varenicline; oral

2.6

19.1

141

556

S18

ICPC

Laceration/cut

1.5

18.9

988

7562

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

55.4

18.9

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.2

18.9

203

965

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

18.8

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

18.8

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

18.8

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

18.8

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

18.8

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

18.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

28.0

18.7

DMA00

NOMESCO Finland

Biopsy of maxillary antrum

28.0

18.7

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

70.3

18.7

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.7

18.6

127

477

R06.0

ICD-10 Finland

Dyspnoea

1.6

18.6

630

4380

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

18.6

443

2808

A02BC03

ATC

lansoprazole; oral

1.5

18.3

753

5471

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

18.3

249

1307

GBB00

NOMESCO Finland

Tracheostomy

5.7

18.3

GDC00

NOMESCO Finland

Lobectomy of lung

25.2

18.2

UKC02

NOMESCO Finland

Cystoscopy

1.7

18.1

390

2396

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.4

18.0

102

J01FA06

ATC

roxithromycin; oral

1.5

18.0

977

7523

J38.7

ICD-10 Finland

Other diseases of larynx

8.4

17.9

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

17.9

882

6653

ZXC95

NOMESCO Finland

Use of surgical navigator

6.0

17.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

17.8

319

1852

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

17.8

188

888

8070/3-C30.0

ICD-O-3

Squamous cell carcinoma, NOS, of nasal cavity

+∞

17.7

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

17.7

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.5

17.6

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

95.6

17.6

UGB02

NOMESCO Finland

Tracheoscopy

28.9

17.4

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

17.3

115

426

D36.7

ICD-10 Finland

Benign neoplasm: Other specified sites

13.9

17.3

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

17.2

935

7180

B01AB10

ATC

tinzaparin; parenteral

2.7

17.1

121

463

N05CF01

ATC

zopiclone; oral

1.5

17.1

796

5924

R04.0

ICD-10 Finland

Epistaxis

2.0

17.0

214

1088

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.9

17.0

103

360

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

11.2

16.7

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

16.7

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

+∞

16.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

16.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

90.6

16.6

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

90.6

16.6

N03AX16

ATC

pregabalin; oral

1.6

16.5

558

3862

Z51.0

ICD-10 Finland

Radiotherapy session

170.9

16.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

170.9

16.5

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

170.9

16.5

J32.1

ICD-10 Finland

Chronic frontal sinusitis

10.8

16.4

R04.2

ICD-10 Finland

Haemoptysis

2.8

16.2

108

400

DPB00

NOMESCO Finland

Partial excision of frontal sinus

47.7

16.0

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.1

16.0

304

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.9

15.9

341

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.5

15.9

130

541

A79

ICPC

Malignancy NOS

60.3

15.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

15.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

15.6

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

15.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

15.6

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

15.6

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

15.6

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

15.6

D10.6

ICD-10 Finland

Benign neoplasm: Nasopharynx

22.1

15.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

15.5

490

3334

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

160.8

15.5

C50

ICD-10 Finland

Malignant neoplasm of breast

160.8

15.5

R07.0

ICD-10 Finland

Pain in throat

2.3

15.5

145

649

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.4

15.4

137

597

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

3.3

15.4

236

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

15.4

853

6543

ZXC96

NOMESCO Finland

Robot assisted procedure

9.0

15.4

ZZR00

NOMESCO Finland

Flap of skin

8.0

15.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

15.3

178

880

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.8

15.2

176

J34.2

ICD-10 Finland

Deviated nasal septum

2.2

15.2

154

716

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

15.1

567

4010

DPA20

NOMESCO Finland

Trephine of frontal sinus

23.5

15.1

L57.0

ICD-10 Finland

Actinic keratosis

2.0

15.1

189

960

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.8

14.7

161

P01AB01

ATC

metronidazole; oral, rectal

1.4

14.7

878

6820

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

14.6

131

572

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

14.6

354

2242

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

14.6

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

14.6

D38.58

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other respiratory organ

+∞

14.6

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

14.6

GBB13

NOMESCO Finland

Revision of tracheostomy

80.5

14.6

XKD00

NOMESCO Finland

Uroflowmetry

1.6

14.5

376

2431

X76

ICPC

Malignant neoplasm breast female

150.7

14.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

150.7

14.5

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

19.2

14.2

SPAT1153

SPAT

Removal of sutures

1.4

14.2

712

5343

L02BG03

ATC

anastrozole; oral

42.7

14.1

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.0

927

7319

J02AC01

ATC

fluconazole; systemic

1.4

13.9

806

6214

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

30.2

13.9

H02AB04

ATC

methylprednisolone; systemic

1.6

13.8

360

2324

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

17.6

13.8

4509

FHL

Other measure in this category

53.6

13.8

J01MA14

ATC

moxifloxacin; systemic

1.9

13.8

213

1171

DHB50

NOMESCO Finland

Turbinoplasty

3.0

13.8

267

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

13.7

185

971

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.1

13.6

128

D38.50

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of maxillary sinus

75.5

13.6

8070/3-C32.1

ICD-O-3

Squamous cell carcinoma, NOS, of supraglottis

+∞

13.5

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

13.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

13.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

13.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

13.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

13.5

R4190

NOMESCO Finland

Nutritional therapy

3.3

13.5

211

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

13.5

279

1690

WW500

NOMESCO Finland

Blood transfusion

3.2

13.4

218

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

13.3

1654

14431

R50.9

ICD-10 Finland

Fever, unspecified

1.7

13.2

287

1763

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

13.2

229

1312

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

13.0

220

1252

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

10.1

13.0

EMA30

NOMESCO Finland

Biopsy of rhinopharynx

28.5

12.9

CCD60

NOMESCO Finland

Transnasal dacryocystorhinostomy

7.4

12.9

WX704

NOMESCO Finland

Intubation

2.1

12.9

154

769

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

13.0

12.9

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.1

12.9

142

686

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

50.2

12.8

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

50.2

12.8

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

12.8

153

764

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

12.8

205

1142

G04BE03

ATC

sildenafil; oral

7.5

12.7

H02AB07

ATC

prednisone; oral

1.6

12.6

343

2242

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

70.1

12.6

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

12.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

12.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

12.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

12.5

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

12.5

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

12.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

12.5

ZX050

NOMESCO Finland

Stereotactic radiotherapy

17.4

12.5

DJA10

NOMESCO Finland

Biopsy of septum of nose

24.4

12.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

130.5

12.4

C90.0

ICD-10 Finland

Multiple myeloma

130.5

12.4

UGC02

NOMESCO Finland

Rigid bronchoscopy

13.2

12.4

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

12.4

299

1890

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

12.2

131

626

D10.7

ICD-10 Finland

Benign neoplasm: Hypopharynx

37.7

12.2

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

37.7

12.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

12.1

410

2819

J01FA09

ATC

clarithromycin; systemic

1.4

12.1

698

5349

R05

ICD-10 Finland

Cough

1.5

12.1

431

3002

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

12.1

874

6965

J01FF01

ATC

clindamycin; systemic

1.4

12.0

629

4737

J20

ICD-10 Finland

Acute bronchitis

1.8

12.0

211

1213

ENA10

NOMESCO Finland

Biopsy of pharynx

10.1

12.0

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

9.3

12.0

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

13.4

11.9

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

11.9

293

1864

TQW99

NOMESCO Finland

Other minor procedure on skin

2.5

11.8

364

M54.5

ICD-10 Finland

Low back pain

1.4

11.8

731

5672

R21

ICPC

Throat symptom/complaint

1.5

11.7

369

2498

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

3.6

11.7

142

ZXB10

NOMESCO Finland

Medial

6.6

11.7

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.4

11.7

405

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

11.7

219

1286

1430

FHL

Laryngoscopy (direct)

16.5

11.7

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

30.1

11.6

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

11.6

610

4596

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

11.5

928

7515

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

11.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

11.5

L02BG06

ATC

exemestane; oral

+∞

11.5

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

11.5

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

11.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

11.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

11.5

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

11.5

C14.1

ICD-10 Finland

Malignant neoplasm of laryngopharynx unspecified

+∞

11.5

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

11.5

DMB40

NOMESCO Finland

Excision of lesion of maxillary antrum trough lateral rhinotomy

120.4

11.4

D38.51

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of other accessory sinus

120.4

11.4

R06AE07

ATC

cetirizine; oral

1.3

11.4

946

7691

R03DC03

ATC

montelukast; oral

1.6

11.3

347

2332

ZZF00

NOMESCO Finland

Graft of adipose tissue

11.8

11.3

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

11.3

131

650

GAA31

NOMESCO Finland

Thoracoscopy

10.6

11.2

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

11.1

928

7541

DAB00

NOMESCO Finland

Excision of lesion of auricle

8.1

11.1

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

11.1

402

2809

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.3

11.0

434

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

11.0

174

968

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

10.9

119

575

R53

ICD-10 Finland

Malaise and fatigue

1.5

10.9

463

3342

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.1

10.8

118

567

E0000UV

ATC

1.3

10.8

871

7040

2391A

ICD-9 Finland

Neoplasm of unspecified nature, Respiratory system

10.6

10.8

A02BA02

ATC

ranitidine; systemic

1.4

10.7

479

3491

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

4.0

10.7

103

5822

FHL

Exploratory thoracotomy and small procedure (eg lung suture)

21.5

10.7

N06AX16

ATC

venlafaxine; oral

1.6

10.7

274

1761

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.6

10.6

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

12.9

10.6

5826

FHL

Lobectomy or bilobectomy

60.2

10.6

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

60.2

10.6

K02.1

ICD-10 Finland

Caries of dentine

1.3

10.6

1270

10864

R08

ICPC

Nose symptom/complaint other

2.6

10.5

286

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.8

10.5

185

1066

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

110.4

10.4

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

10.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

10.4

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

10.4

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

10.4

C13.9

ICD-10 Finland

Malignant neoplasm: Hypopharynx, unspecified

+∞

10.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

10.4

L02BB04

ATC

enzalutamide; oral

+∞

10.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

10.4

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

10.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

10.4

8070/2-C32.0

ICD-O-3

Squamous cell carcinoma in situ, NOS, of glottis

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

10.4

C31.0

ICD-10 Finland

Malignant neoplasm: Maxillary sinus

+∞

10.4

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

10.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

10.4

21299

ICD-8 Finland

Benign neoplasm of respiratory system, Unspecified site

+∞

10.4

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

10.4

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

10.4

D14

ICD-10 Finland

Benign neoplasm of middle ear and respiratory system

+∞

10.4

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

10.4

XW000

NOMESCO Finland

Bone marrow biopsy

2.6

10.4

297

1240

FHL

Bronchoscopy

3.9

10.4

106

R03BA02

ATC

budesonide; inhalant

1.5

10.3

392

2761

A06AD11

ATC

lactulose; oral

1.5

10.3

336

2288

TGD00

NOMESCO Finland

Needle biopsy of lung

16.1

10.3

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

12.1

10.3

GD6AD

NOMESCO Finland

CT of chest and neck

32.6

10.3

4760A

ICD-9 Finland

Chronic laryngitis and laryngotracheitis, Chronic laryngitis

8.8

10.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.8

10.3

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.1

10.3

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

23.4

10.2

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

23.4

10.2

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

10.2

238

1489

R95

ICPC

Chron obstructive pulmonary disease

2.5

10.2

324

Z01.2

ICD-10 Finland

Dental examination

1.3

10.1

881

7182

4239

FHL

Other measure in this category

7.9

10.1

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

11.3

10.0

ZZA00

NOMESCO Finland

Split skin graft

2.7

10.0

236

R49.09

ICD-10 Finland

Unspecified dysphonia

4.0

10.0

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.8

10.0

157

871

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

7.2

10.0

R51.80

ICD-10 Finland

Headache

1.6

9.9

289

1919

R06AX22

ATC

ebastine; oral

1.5

9.9

345

2388

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

9.8

135

716

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

9.8

143

775

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.7

9.8

233

50808

ICD-8 Finland

Other diseases of upper respiratory tract, Alii definiti

8.1

9.8

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

26.1

9.8

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

26.1

9.8

AA1AD

NOMESCO Finland

CT of head and brain

1.4

9.8

573

4381

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

4.0

9.8

J01DA06

ATC

[U] cefuroxime; systemic

1.5

9.8

325

2225

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

9.7

417

3011

WX400

NOMESCO Finland

Inhalation anesthesy

2.2

9.7

422

J32.4

ICD-10 Finland

Chronic pansinusitis

3.6

9.7

118

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

2.4

9.7

341

R02

ICPC

Shortness of breath/dyspnoea

1.6

9.7

271

1780

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

55.2

9.6

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

9.6

360

2527

R03BA05

ATC

fluticasone; inhalant

1.5

9.6

395

2828

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

9.1

9.5

D10.5

ICD-10 Finland

Benign neoplasm: Other parts of oropharynx

10.0

9.5

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.0

9.5

4226

FHL

Posterior radical surgery and possible etmoidectomy

4.7

9.5

M02AA07

ATC

piroxicam; topical

1.3

9.5

869

7126

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

9.4

269

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

100.3

9.4

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

100.3

9.4

J04.0

ICD-10 Finland

Acute laryngitis

2.8

9.4

221

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

9.4

308

2101

ZQZ00

NOMESCO Finland

Treatment of several skin areas

17.6

9.4

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

9.4

DPC35

NOMESCO Finland

Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus

+∞

9.4

DPB10

NOMESCO Finland

Partial excision of sphenoidal sinus

+∞

9.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

9.4

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

9.4

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

9.4

8240/3-C34.9

ICD-O-3

Neuroendocrine tumor, NOS, of lung, NOS

+∞

9.4

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

9.4

L02BX03

ATC

abiraterone; oral

+∞

9.4

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

9.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

9.4

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

9.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

9.4

D02.0

ICD-10 Finland

Carcinoma in situ: Larynx

+∞

9.4

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

9.4

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

9.4

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

9.3

105

513

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

9.2

169

987

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

9.2

419

3061

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

9.2

399

2890

ELB40

NOMESCO Finland

Partial parotidectomy

4.0

9.1

R01AD01

ATC

beclometasone; nasal

1.5

9.1

341

2393

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

9.1

129

693

Z50.5

ICD-10 Finland

Speech therapy

3.5

9.0

115

HAE99

NOMESCO Finland

Other reconstruction of breast

15.6

9.0

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.8

9.0

KMAK

NOMESCO Finland

1.3

8.9

1151

9861

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

18.6

8.9

R85

ICPC

Malignant neopl respiratory other

24.1

8.9

J38.6

ICD-10 Finland

Stenosis of larynx

24.1

8.9

ZXC99

NOMESCO Finland

Other special technic in surgery

12.6

8.9

51925

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis NUD

6.8

8.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

8.7

332

2337

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

8.7

387

2812

J32.8

ICD-10 Finland

Other chronic sinusitis

7.6

8.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

8.6

580

4530

R06AX27

ATC

desloratadine; oral

1.4

8.6

521

4001

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

8.6

165

977

N05BA01

ATC

diazepam; systemic, rectal

1.5

8.6

313

2185

WX892

NOMESCO Finland

Monitored bed care

1.7

8.6

165

978

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.7

8.6

204

G04CA02

ATC

tamsulosin; oral

1.3

8.6

607

4779

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

16.3

8.5

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

8.5

442

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

8.5

492

3745

4784A

ICD-9 Finland

Other diseases of upper respiratory tract, Polyp of vocal cord or larynx[POLYPUS PLICAE VOCALIS]

9.0

8.5

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.0

8.5

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

8.5

150

865

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

8.5

239

1572

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.5

1404

12384

ENB00

NOMESCO Finland

Excision or exploration of lesion of pharynx

27.6

8.5

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

8.5

603

4748

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

20.1

8.5

J05AB11

ATC

valaciclovir; oral

1.5

8.5

255

1705

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

90.3

8.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

90.3

8.4

DJB10

NOMESCO Finland

Excision of septum of nose

90.3

8.4

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

4.4

8.4

J01EA01

ATC

trimethoprim; systemic

1.4

8.3

473

3588

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

8.3

1604

14394

L02BX02

ATC

degarelix; parenteral

+∞

8.3

L02BB01

ATC

flutamide; oral

+∞

8.3

XX1XN

NOMESCO Finland

Other isotope examination

+∞

8.3

QA9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head or neck, unspecified

+∞

8.3

C32.2

ICD-10 Finland

Malignant neoplasm: Subglottis

+∞

8.3

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

8.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

8.3

21220

ICD-8 Finland

Benign neoplasm of respiratory system, Trachea

+∞

8.3

1CD02

NOMESCO Finland

+∞

8.3

L01AX03

ATC

temozolomide; systemic

+∞

8.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

8.3

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

8.3

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

8.3

134

755

J39.2

ICD-10 Finland

Other diseases of pharynx

4.1

8.3

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.4

8.3

272

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

8.3

226

1478

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.5

8.3

108

M79.1

ICD-10 Finland

Myalgia

1.5

8.2

257

1732

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.5

8.2

103

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.4

8.2

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

8.2

309

2172

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

8.2

452

A28

ICPC

Limited function/disability NOS

1.5

8.2

328

2334

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

2.8

8.1

182

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

5.4

8.1

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.1

8.1

137

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

33.4

8.1

R07.3

ICD-10 Finland

Other chest pain

1.6

8.1

207

1331

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

17.2

8.1

JN6AD

NOMESCO Finland

CT of torso and neck

6.8

8.1

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

5.0

8.0

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

8.0

178

1104

J01DC02

ATC

cefuroxime; systemic

1.8

8.0

124

690

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

8.0

226

1490

J02AB02

ATC

ketoconazole; oral

2.4

7.9

265

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.4

7.9

258

TQW40

NOMESCO Finland

Remowal of suture of skin

1.8

7.9

134

767

EP2AT

NOMESCO Finland

Neck soft tissue cytology with ultrasound guidance

13.0

7.9

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

13.0

7.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

7.9

624

4988

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

7.9

331

ZX112

NOMESCO Finland

Subcutaneous

4.1

7.8

ZX100

NOMESCO Finland

Oral

3.5

7.8

JFB30

NOMESCO Finland

Right hemicolectomy

5.7

7.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.3

7.8

SPAT1301

SPAT

No procedures

1.3

7.8

711

5798

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

7.8

262

H65.3

ICD-10 Finland

Chronic mucoid otitis media

3.0

7.8

147

R03AC13

ATC

formoterol; inhalant

1.9

7.7

112

607

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

45.1

7.7

TKE10

NOMESCO Finland

Puncture of prostate

45.1

7.7

XX1AD

NOMESCO Finland

Other CT-examination

45.1

7.7

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.2

7.7

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.7

547

4304

J45

ICD-10 Finland

Asthma

1.6

7.7

200

1293

A01AB09

ATC

miconazole; local oral

1.6

7.6

190

1212

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.6

149

889

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

18.4

7.6

UJH02

NOMESCO Finland

Anoscopy

2.0

7.6

468

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.7

7.5

R05

ICPC

Cough

1.4

7.5

448

3429

S29

ICPC

Skin symptom/complaint other

1.4

7.5

331

2402

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

7.4

649

5256

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

7.4

1232

10806

-1

NOMESCO Finland

1.3

7.4

672

5469

N06AX11

ATC

mirtazapine; oral

1.3

7.4

680

5542

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.4

357

2630

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

7.4

154

937

DM1BG

NOMESCO Finland

Paranasal sinuses and face area standard MRI examination with high intensity magnet

80.3

7.4

C320, 8077, 2

ICD-O-3

80.3

7.4

L02AE04

ATC

triptorelin; parenteral

80.3

7.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

80.3

7.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

7.4

355

2616

J33

ICD-10 Finland

Nasal polyp

5.6

7.4

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

4.3

7.3

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.7

7.3

EL4AT

NOMESCO Finland

Salivary gland cytology with ultrasound guidance

8.4

7.3

R29

ICPC

Respiratory symptom/complaint other

1.7

7.3

136

803

21208

ICD-8 Finland

Benign neoplasm of respiratory system, Nasi, loco multiplici

+∞

7.3

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

7.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

7.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

7.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

7.3

C44.90

ICD-10 Finland

Unspecified localization of malignant tumor of the skin without histology

+∞

7.3

C13.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of hypopharynx

+∞

7.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

7.3

8010/3-C34.9

ICD-O-3

Carcinoma, NOS, of lung, NOS

+∞

7.3

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

7.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

7.3

C32

ICD-10 Finland

Malignant neoplasm of larynx

+∞

7.3

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

7.3

C72.2

ICD-10 Finland

Malignant neoplasm: Olfactory nerve

+∞

7.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

7.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

7.3

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

7.3

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

+∞

7.3

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

7.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

7.3

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

7.3

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

7.3

L01CA04

ATC

vinorelbine; systemic

+∞

7.3

GCA05

NOMESCO Finland

Bronchoscopic laser therapy of lesion of bronchus

+∞

7.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.0

7.3

475

EMA10

NOMESCO Finland

Biopsy of tonsil

9.4

7.3

GDA10

NOMESCO Finland

Biopsy of lung

9.4

7.3

D07AC01

ATC

betamethasone; topical

1.3

7.3

770

6398

N05BA04

ATC

oxazepam; oral

1.3

7.3

528

4166

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

7.2

297

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

7.2

180

1152

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.6

7.2

202

H01

ICPC

Ear pain/earache

1.6

7.2

195

1275

UJC12

NOMESCO Finland

Flexible oesophagoscopy

4.1

7.2

M79.6

ICD-10 Finland

Pain in limb

1.3

7.1

769

6399

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

30.1

7.1

M03BX02

ATC

tizanidine; oral

1.2

7.1

1394

12439

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

7.1

201

1328

S77

ICPC

Malignant neoplasm of skin

12.0

7.1

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

7.1

224

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

6.0

7.1

J01.1

ICD-10 Finland

Acute frontal sinusitis

3.0

7.0

123

DMA10

NOMESCO Finland

Exploration of maxillary antrum

8.8

7.0

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

7.0

100

540

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

7.0

245

R06.5

ICD-10 Finland

Mouth breathing

1.6

7.0

189

1234

R31

ICD-10 Finland

Unspecified haematuria

1.5

6.9

204

1358

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

6.9

325

2382

KC1GB

NOMESCO Finland

Cystography with X-ray

13.8

6.9

N06AB10

ATC

escitalopram; oral

1.4

6.9

374

2816

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

6.9

144

881

M25.5

ICD-10 Finland

Pain in joint

1.3

6.9

586

4727

C05AA08

ATC

fluocortolone; rectal, topical

1.4

6.8

308

2241

L01

ICPC

Neck symptom/complaint

1.5

6.8

265

1875

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.5

6.8

199

1324

R51.81

ICD-10 Finland

Facial pain NOS

2.4

6.8

227

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

4.0

6.8

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

4.0

6.8

H65.2

ICD-10 Finland

Chronic serous otitis media

3.6

6.8

DQW99

NOMESCO Finland

Other operation on larynx

40.1

6.8

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

40.1

6.8

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.9

6.8

127

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.9

6.7

462

D38.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified

16.7

6.7

ZXC60

NOMESCO Finland

Application of heat

2.7

6.7

167

R03BB01

ATC

ipratropium bromide; inhalant

1.8

6.7

100

550

R01AD11

ATC

triamcinolone; nasal

1.6

6.7

188

1238

A03

ICPC

Fever

1.4

6.7

282

2026

J01

ICD-10 Finland

Acute sinusitis

1.9

6.7

478

B01AB04

ATC

dalteparin; parenteral

1.9

6.7

464

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

6.7

357

2678

M01AB05

ATC

diclofenac; systemic, rectal

1.2

6.7

1584

14381

GDB10

NOMESCO Finland

Wedge resection of lung

22.5

6.7

CBA10

NOMESCO Finland

Biopsy of eyelid

4.9

6.7

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.8

6.6

139

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

6.6

429

A98

ICPC

Health maint/preventive medicine

1.3

6.6

2466

23603

J38.4

ICD-10 Finland

Oedema of larynx

5.5

6.6

N05CF02

ATC

zolpidem; oral

1.4

6.6

358

2696

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

6.6

240

1676

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.1

6.6

107

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

6.6

113

651

SPAT1263

SPAT

Sampling

1.2

6.5

929

7973

ZX114

NOMESCO Finland

Intramuscular

3.3

6.5

R52.9

ICD-10 Finland

Pain, unspecified

1.6

6.5

166

1068

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

10.0

6.5

M01AH05

ATC

etoricoxib; oral

1.2

6.5

1340

11971

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

6.5

314

2314

L02AE03

ATC

goserelin; implant

6.8

6.5

G47.3

ICD-10 Finland

Sleep apnoea

1.3

6.5

502

3991

B07.9

ICD-10 Finland

Verruca simplex

2.1

6.5

302

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

6.5

167

1081

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.8

6.4

136

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

6.4

138

851

WF090

NOMESCO Finland

Profylactic radiotherapy

70.0

6.4

DPB20

NOMESCO Finland

Obliteration of frontal sinus

70.0

6.4

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

70.0

6.4

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

70.0

6.4

R03AC12

ATC

salmeterol; inhalant

1.8

6.4

112

649

C07AB07

ATC

bisoprolol; oral

1.2

6.4

1150

10124

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

6.4

189

1263

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.0

6.4

115

L02

ICPC

Back symptom/complaint

1.6

6.4

172

1121

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

6.4

388

2975

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.7

6.4

144

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

6.4

205

1397

R39.1

ICD-10 Finland

Other difficulties with micturition

2.1

6.3

322

J01FA15

ATC

telithromycin; oral

1.5

6.3

206

1405

WX707

NOMESCO Finland

Fiberoscopic intubation

8.2

6.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

6.3

670

5553

G04BE01

ATC

alprostadil; parenteral, urethral

2.7

6.3

155

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

6.0

6.3

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.5

6.3

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

6.3

116

685

R23

ICPC

Voice symptom/complaint

2.6

6.3

170

N06AX21

ATC

duloxetine; oral

1.5

6.3

205

1400

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.8

6.3

DCB00

NOMESCO Finland

Excision of lesion of middle ear

18.0

6.3

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

6.3

782

6607

197

Kela drug reimbursment

Sunitinib

+∞

6.2

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

6.2

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

+∞

6.2

8070/3-C13.9

ICD-O-3

Squamous cell carcinoma, NOS, of hypopharynx, NOS

+∞

6.2

EEB10

NOMESCO Finland

Maxillectomy

+∞

6.2

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

6.2

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

6.2

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

+∞

6.2

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

6.2

128

Kela drug reimbursment

Cancers of female genital organs

+∞

6.2

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.2

L01CB01

ATC

etoposide; systemic

+∞

6.2

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.2

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

6.2

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

+∞

6.2

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

6.2

180

Kela drug reimbursment

Interferon alfa

+∞

6.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.2

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

+∞

6.2

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

6.2

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

6.2

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

6.2

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

+∞

6.2

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

6.2

C12

ICD-10 Finland

Malignant neoplasm of piriform sinus

+∞

6.2

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

6.2

21209

ICD-8 Finland

Benign neoplasm of respiratory system, Nasi, NUD

+∞

6.2

9522/3-C30.0

ICD-O-3

Olfactory neuroblastoma of nasal cavity

+∞

6.2

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

+∞

6.2

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.2

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

6.2

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

6.2

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

6.2

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

6.2

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

+∞

6.2

C90.2

ICD-10 Finland

Extramedullary plasmacytoma

+∞

6.2

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

6.2

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.3

6.2

239

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

26.7

6.2

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.4

6.2

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

6.2

228

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

6.2

596

4877

N63

ICD-10 Finland

Unspecified lump in breast

2.0

6.2

384

DKW99

NOMESCO Finland

Other procedures for control of epistaxis

6.3

6.2

J47

ICD-10 Finland

Bronchiectasis

2.5

6.1

184

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.1

535

4324

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.6

6.1

160

N03AX12

ATC

gabapentin; oral

1.4

6.1

316

2362

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

6.1

402

3124

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.8

6.1

540

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.1

649

5380

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

6.1

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

6.0

182

1222

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

6.0

436

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

6.0

147

939

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.0

1146

10127

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

6.0

1238

11028

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

6.0

129

796

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726)

425

700

6.87

252.31

1.5

1.3

—

(40768804) Tissue Pathology biopsy report

1569

7532

3.17

217.06

2.7

1.7

—

(3002256) Pathology report gross observation

528

1843

3.24

117.27

1.3

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1448

9627

1.94

69.23

4.9

3.9

35.2

35.7

g/l

2.85

1340

8839

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1633

11299

1.93

69.21

6.4

3.9

12.0

umol/l

0.05

1552

10585

(3013650) Neutrophils [#/volume] in Blood by Automated count

1763

12772

1.87

62.14

8.9

6.5

4.3

e9/l

0.10

1524

10977

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1450

9997

1.84

58.76

4.2

3.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2261

17947

1.93

57.63

8.5

5.5

80.7

76.3

u/l

2.41

2137

16652

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

311

1212

2.74

54.72

3.7

1.5

44.3

3.8

ug/l

0.85

257

897

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1466

10328

1.79

53.68

6.4

5.4

1.2

mmol/l

0.34

1369

9186

(3002582) Erythrocytes [#/volume] in Urine

1060

6963

1.79

47.79

3.6

3.0

156.8

88.7

e6/l

0.33

811

5296

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

12.60

46.97

1.2

—

(42870588) Differential panel, method unspecified - Blood

1138

7661

1.76

46.96

5.8

5.5

—

(3044640) Blood type and Crossmatch panel - Blood

1005

6534

1.79

46.69

2.5

2.2

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1556

11478

1.71

45.77

7.4

5.8

1.2

mmol/l

0.84

1300

9670

(3018418) pH of Serum or Plasma

1006

6576

1.78

45.68

4.2

3.3

7.4

0.05

216

1156

(3007853) Bacteria identified in Skin by Aerobe culture

514

2712

2.07

44.83

1.9

1.8

—

(3042936) Bacteria identified in Isolate by Culture

577

3206

1.98

43.45

2.1

2.0

—

(3006315) Basophils [#/volume] in Blood

1555

11596

1.68

42.86

6.2

5.5

0.0

e9/l

0.36

1318

9994

(3006504) Eosinophils/100 leukocytes in Blood

1456

10688

1.68

42.51

6.5

5.7

2.9

3.0

1.07

1360

9872

(3030467) Casts [#/volume] in Urine by Automated count

966

6347

1.75

42.47

3.4

2.9

0.4

e6/l

0.40

715

4722

(3023368) Bacteria identified in Blood by Culture

944

6166

1.76

42.34

4.6

3.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

599

3399

1.94

42.31

4.4

2.7

0.8

mmol/l

2.92

562

3115

(3018095) Leukocytes [#/volume] in Urine

1176

8170

1.70

42.19

4.1

3.4

67.9

101.7

e6/l

1.12

853

5727

(3001604) Monocytes [#/volume] in Blood

1544

11526

1.67

42.12

6.1

5.5

0.6

e9/l

1.48

1307

9921

(3033658) Prothrombin time (PT) actual/Normal

872

5580

1.78

41.92

4.3

3.6

88.9

87.0

1.31

854

5432

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

101

226

4.58

41.87

1.2

1.1

—

(3019198) Lymphocytes [#/volume] in Blood

1576

11841

1.67

41.82

6.2

5.6

1.9

e9/l

0.59

1365

10369

(3019069) Monocytes/100 leukocytes in Blood

1457

10736

1.67

41.62

6.7

6.0

8.8

8.7

0.54

1369

9961

(3013115) Eosinophils [#/volume] in Blood

1590

11999

1.66

41.26

6.4

5.7

0.2

e9/l

1.40

1383

10485

(3002030) Lymphocytes/100 leukocytes in Blood

1484

11012

1.66

41.06

6.6

5.8

26.8

27.6

1.97

1382

10153

(3022096) Basophils/100 leukocytes in Blood

1415

10390

1.66

40.66

6.4

5.8

0.7

1.55

1322

9606

(3032080) INR in Blood by Coagulation assay

1328

9663

1.65

39.05

10.2

9.8

1.3

inr

1.20

396

2715

(36304419) Bacteria [Presence] in Urine

928

6168

1.72

38.40

3.4

2.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

114

300

3.91

38.19

1.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1785

14047

1.63

37.79

5.5

4.4

6.7

6.8

mmol/l

1.39

1704

13097

(3015377) Calcium [Moles/volume] in Serum or Plasma

1040

7169

1.67

37.33

3.3

2.1

2.4

mmol/l

0.33

925

6023

(3018010) Neutrophils/100 leukocytes in Blood

1452

10912

1.62

36.75

6.4

5.6

57.9

57.6

0.52

1358

10123

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

422

2240

2.02

35.66

3.6

3.1

249.6

234.7

u/l

1.13

403

2084

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

189

716

2.74

34.84

2.4

2.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

435

2357

1.98

34.62

2.5

2.3

8.8

7.8

umol/l

0.22

377

2036

(40768795) Lymph node Pathology biopsy report

8.29

34.23

1.2

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

747

4830

1.72

33.43

2.8

2.4

4.5

5.0

e6/l

0.72

632

4172

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

644

4003

1.77

33.12

2.8

2.1

2.5

2.4

mmol/l

2.10

553

3413

(40758558) Short blood count panel - Blood

813

5392

1.69

33.05

7.0

4.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

768

5036

1.70

32.50

2.4

2.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1864

15183

1.56

31.19

5.2

4.2

1060.9

2054.8

e6/l

0.45

230

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

129

427

3.11

30.35

1.7

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

114

5.26

29.08

3.2

1.7

7.9

4.0

nmol/l

0.63

107

(3026782) Osmolality of Urine

676

4458

1.66

27.35

3.0

2.6

550.0

555.1

mosm/kgh2o

0.23

570

3726

(3044889) 12 lead EKG panel

2048

17278

1.53

27.27

4.4

3.8

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2106

17885

1.54

27.11

4.6

4.1

13.3

11.7

mm/h

4.45

1966

16552

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

456

2708

1.80

26.90

7.5

7.1

5.2

5.1

kpa

0.94

442

2577

(3027801) Oxygen [Partial pressure] in Arterial blood

456

2708

1.80

26.90

7.5

7.1

12.4

11.7

kpa

2.03

440

2574

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

562

3563

1.70

26.30

3.3

2.7

2.2

2.4

e6/l

0.15

301

1906

(3003396) Base excess in Arterial blood by calculation

451

2688

1.79

26.25

7.6

7.1

1.4

1.2

mmol/l

0.61

363

2047

(3021589) Normoblasts [#/volume] in Blood

1317

10252

1.49

25.09

11.2

8.4

0.0

e9/l

0.19

1059

8354

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

572

3718

1.66

24.16

2.0

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

990

7328

1.51

23.78

2.7

2.4

56.6

59.6

u/l

1.45

923

6746

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

395

2336

1.79

23.45

4.1

3.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

587

3875

1.63

23.23

3.1

2.5

0.9

1.2

e6/l

1.14

327

2204

(3016502) Oxygen saturation in Arterial blood

406

2432

1.77

23.05

7.8

7.4

95.6

95.1

1.00

395

2336

(3000494) Fungus identified in Specimen by Culture

441

2739

1.71

21.96

1.6

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

370

2205

1.77

21.31

8.5

7.9

121.8

123.3

g/l

0.68

361

2120

(3005719) IgG [Mass/volume] in Serum or Plasma

283

1553

1.90

21.28

2.4

2.2

10.3

10.8

g/l

0.93

260

1417

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

233

1197

2.02

21.23

9.7

9.5

24.8

24.3

mmol/l

1.35

221

1093

(3042631) Mycobacterium sp identified in Specimen

273

3.17

21.10

2.4

3.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

981

7392

1.48

21.02

3.4

2.7

34.3

36.4

u/l

0.28

935

6991

(3000991) Gas panel - Venous blood

332

1927

1.81

20.89

8.8

8.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

231

1195

2.01

20.63

9.3

10.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

451

2901

1.65

19.52

7.5

6.5

104.3

mmol/l

0.11

443

2828

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

10.06

19.38

2.2

1.0

18.5

17.9

u/ml

0.06

(3037467) Urinalysis macro (dipstick) panel - Urine

1896

16300

1.41

18.87

4.8

4.1

—

(3023419) Bacteria identified in Sputum by Culture

308

2.91

18.86

2.2

2.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2640

24191

1.58

18.78

19.5

12.8

24.3

23.8

mg/l

0.40

2262

18787

(40768800) Prostate Pathology biopsy report

171

3.62

18.77

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

327

1957

1.75

18.46

2.5

2.3

34.0

62.9

u/l

0.61

267

1652

(3018677) aPTT in Platelet poor plasma by Coagulation assay

539

3670

1.57

18.33

2.1

2.0

30.4

30.0

0.72

526

3559

(3003458) Phosphate [Moles/volume] in Serum or Plasma

455

2984

1.61

18.13

5.3

5.7

1.1

1.0

mmol/l

0.55

423

2737

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

299

1755

1.78

18.04

2.7

2.1

0.2

g/l

0.61

283

1592

(3028026) IgM [Mass/volume] in Serum or Plasma

227

1225

1.92

17.92

1.6

1.4

1.1

g/l

1.59

209

1120

(3002385) Erythrocyte distribution width [Ratio]

2228

19836

1.43

17.30

21.7

15.2

13.8

13.6

8.30

2196

19318

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

10.05

16.70

5.3

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

459

3093

1.57

16.19

2.6

2.7

21.3

23.4

2.53

403

2625

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

396

2579

1.61

16.14

2.0

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

260

1520

1.77

15.87

1.8

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

324

2017

1.68

15.77

2.6

1.8

361.2

365.3

nmol/l

0.11

312

1829

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

393

2572

1.60

15.68

2.0

1.7

—

(3012501) Base excess in Blood by calculation

114

498

2.34

15.65

3.1

4.7

2.5

2.6

mmol/l

0.23

327

(40768797) Stomach Pathology biopsy report

471

3223

1.54

15.47

1.3

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

328

2072

1.65

15.07

7.8

6.9

1.3

1.4

mmol/l

0.81

316

1990

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2499

22929

1.44

14.76

17.3

11.7

80.0

79.1

ml/min/173m2

1.37

2146

18483

(3014007) Fractional oxyhemoglobin in Arterial blood

245

1439

1.76

14.71

9.7

9.3

94.0

93.3

1.45

245

1434

(3019550) Sodium [Moles/volume] in Serum or Plasma

2719

25387

1.54

14.52

21.6

15.2

139.5

139.8

mmol/l

5.71

2681

24682

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

244

1437

1.76

14.51

9.7

9.2

0.7

0.26

244

1426

(3022948) Iron [Moles/volume] in Serum or Plasma

514

3635

1.50

14.38

2.5

2.6

12.0

13.3

umol/l

4.08

482

3345

(3004789) Transferrin [Mass/volume] in Serum or Plasma

479

3339

1.51

14.36

2.5

2.6

2.3

g/l

0.34

452

3086

(3022145) Colonoscopy Study observation

359

2369

1.58

13.76

1.4

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1171

9620

1.35

13.72

3.1

2.8

143.9

132.6

ug/l

0.51

1104

8881

(3027945) Reticulocytes/100 erythrocytes in Blood

396

2675

1.55

13.70

2.3

2.2

1.9

1.8

1.25

368

2337

(3052851) Hemolysis interference index of Serum or Plasma

133

656

2.07

13.57

3.3

3.5

—

(40761536) Microorganisms panel - Urine sediment

291

1832

1.65

13.52

3.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2719

25469

1.51

13.42

21.8

15.3

4.0

mmol/l

1.48

2677

24724

(3010421) pH of Blood

123

592

2.12

13.39

3.0

4.5

7.4

0.89

112

491

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2036

18171

1.34

13.36

4.2

3.7

14.9

14.8

pmol/l

0.33

1846

16461

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

772

5960

1.39

13.32

2.4

2.2

3.1

2.9

mg/l

1.17

676

5053

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

437

2.31

13.32

2.8

2.0

6171.6

137.5

u/ml

0.49

355

(3042111) Morphology [Interpretation] in Bone marrow Narrative

286

2.63

13.24

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

141

3.37

13.13

2.1

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

659

4969

1.41

13.01

4.7

4.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

451

3169

1.49

12.93

1.7

—

(3026008) Bacteria identified in Urine by Culture

831

6533

1.37

12.74

3.5

3.1

—

(40768793) Breast Pathology biopsy report

127

3.42

12.33

1.3

1.1

—

(3019060) Gas panel - Arterial blood

258

1614

1.65

12.28

4.0

4.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

408

2.29

12.27

3.2

3.4

58.5

57.5

0.33

408

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

671

5121

1.39

12.26

1.9

1.8

1.3

1.2

mg/l

0.32

538

3914

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1233

10343

1.32

12.05

2.0

95.7

94.4

pmol/l

0.41

647

5418

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1607

14011

1.30

11.67

2.9

2.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

400

2.26

11.52

3.1

3.3

4.3

4.2

e9/l

0.19

400

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

125

641

1.99

11.51

1.6

1.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

480

3493

1.44

11.41

24.5

27.8

1.4

inr

0.17

482

(3000492) Spirometry study

337

2291

1.53

11.25

1.6

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

642

4927

1.38

11.23

4.2

3.8

329.9

516.8

ng/l

1.30

495

3953

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

276

1799

1.59

11.11

3.8

3.1

1.2

mmol/l

0.51

250

1532

(3017181) Myelocytes/100 leukocytes in Blood

276

1803

1.58

11.00

3.7

3.9

0.7

0.03

387

(3004809) Band form neutrophils/100 leukocytes in Blood

265

2.52

10.99

2.6

2.5

1.2

1.3

0.06

192

(3035350) Ketones [Presence] in Urine by Test strip

1351

11575

1.29

10.94

3.9

3.5

0.0

estimate

0.00

290

1990

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2752

26046

1.46

10.81

21.9

14.6

81.2

80.2

umol/l

0.56

2752

26039

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2401

22244

1.34

10.51

5.1

4.5

1.9

2.1

mu/l

1.06

2204

20225

(1616796) Gas panel - Central venous blood

104

518

2.04

10.41

3.0

3.9

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

150

845

1.81

10.41

1.8

1.6

126.7

338.3

titre

—

(3049717) Cytology report of Urine Cyto stain

140

772

1.85

10.40

2.7

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1349

11606

1.29

10.40

5.2

4.8

0.0

estimate

0.50

298

2038

(3009261) Glucose [Presence] in Urine by Test strip

1363

11742

1.28

10.40

4.0

3.6

0.0

estimate

1.34

282

1936

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2750

26058

1.45

10.39

12.1

9.0

26.7

26.8

u/l

0.04

2674

24985

(3002179) Metamyelocytes/100 leukocytes in Blood

255

1661

1.58

10.29

3.5

3.7

0.5

0.03

286

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1137

9614

1.29

9.91

2.4

2.2

76.7

77.7

nmol/l

0.51

1025

8514

(3023520) Reticulocytes [#/volume] in Blood

291

1971

1.53

9.87

2.5

2.2

74.9

68.8

e9/l

1.94

221

1497

(3009445) Proteinase 3 Ab [Units/volume] in Serum

178

1071

1.70

9.84

2.1

1.6

12.5

18.7

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

544

4156

1.37

9.65

1.5

1.3

2.6

g/l

0.05

346

2458

(3020779) Urea [Moles/volume] in Serum or Plasma

304

2089

1.50

9.63

7.0

7.6

9.8

10.6

mmol/l

1.12

290

1974

(4010399)

263

1755

1.54

9.55

1.5

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1140

9681

1.28

9.49

4.4

3.7

90.9

84.3

ng/l

0.04

815

6819

(40761511) CBC panel - Blood by Automated count

2671

25261

1.39

9.44

17.2

12.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

260

1735

1.54

9.44

3.8

4.0

0.1

0.33

357

(3026389) Candida sp identified in Specimen by Organism specific culture

267

2.39

9.40

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

213

1359

1.61

9.39

1.6

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

262

2.39

9.31

4.3

2.0

240.4

71.8

u/ml

0.37

236

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1745

15624

1.26

9.25

3.4

3.0

54.9

48.2

u/l

1.42

1633

14444

(3017143) Hepatitis C virus Ab [Presence] in Serum

314

2192

1.48

9.20

1.5

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

361

2591

1.44

9.16

1.5

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

214

1376

1.60

9.14

1.3

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

2356

21904

1.30

9.13

19.1

13.9

40.0

40.1

0.09

1649

15263

(40768443) Skin Pathology biopsy report

154

910

1.73

9.11

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

173

1056

1.68

9.08

1.7

1.6

1.7

1.5

g/l

1.62

146

907

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

133

2.96

8.92

1.2

1.3

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

903

7500

1.29

8.83

3.2

3.1

1233.0

1495.1

ng/l

1.57

788

6414

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

453

2.02

8.81

1.8

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

211

1367

1.58

8.73

1.9

1.6

—

(3013512) EKG study

865

7166

1.29

8.59

4.4

4.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

103

552

1.90

8.43

4.5

3.1

7.5

8.0

kpa

2.04

511

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

314

2231

1.45

8.40

3.0

3.1

291.7

219.4

ng/l

0.48

289

2035

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

341

2.14

8.30

1.6

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

284

2.24

8.20

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

240

2.36

8.19

4.9

4.0

—

(3025159) Blasts/100 leukocytes in Blood

243

1653

1.51

8.08

3.9

4.1

0.0

0.3

0.56

307

(3026493) Urate [Moles/volume] in Serum or Plasma

799

6617

1.28

7.84

3.0

2.4

6086.1

5655.8

umol/l

0.09

689

5698

(3035637) Corticotropin [Mass/volume] in Plasma

209

2.41

7.75

1.7

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

491

1.90

7.65

2.8

2.5

15.8

16.7

0.77

270

(3037756) Immunofixation for Serum or Plasma

415

1.98

7.60

1.4

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

930

7870

1.26

7.58

2.2

209.1

250.5

u/l

0.75

882

7359

(3002032) Base excess in Venous blood by calculation

314

2275

1.42

7.55

4.1

3.5

1.8

1.9

mmol/l

0.15

264

1838

(3021447) Carbon dioxide [Partial pressure] in Venous blood

314

2278

1.42

7.50

4.0

3.5

5.9

kpa

0.14

304

2200

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

177

1142

1.58

7.49

4.7

3.9

24.1

24.2

mmol/l

0.12

166

1012

(40768441) Liver Pathology biopsy report

103

3.03

7.46

1.2

1.4

—

(3051651) Icteric interference index of Serum or Plasma

114

2.91

7.43

2.5

4.2

—

(3048689) Calprotectin [Mass/mass] in Stool

356

2652

1.39

7.29

2.4

2.3

152.0

148.6

ug/g

0.05

276

2093

(3039000) Anion gap in Blood

507

1.86

7.27

5.7

6.8

11.4

mmol/l

0.01

451

(3008152) Bicarbonate [Moles/volume] in Arterial blood

225

1542

1.49

7.24

6.5

6.7

24.8

24.5

mmol/l

0.55

215

1434

(3018572) Chloride [Moles/volume] in Blood

508

1.86

7.22

5.8

6.8

105.0

mmol/l

0.00

452

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

144

892

1.64

7.20

1.9

1.8

4.3

1.6

ug/l

1.09

130

773

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

442

3414

1.34

7.19

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

124

740

1.70

7.15

5.7

5.8

1.2

1.3

mmol/l

0.95

114

645

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

3.35

7.10

4.4

1.1

8.0

58.6

u/ml

—

(3045142) Bone marrow Pathology biopsy report

165

2.50

6.92

1.2

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

101

576

1.78

6.84

2.8

2.9

1.5

1.6

mg/l

0.87

520

(3020630) Protein [Mass/volume] in Serum or Plasma

263

1886

1.43

6.71

2.2

1.6

66.1

67.0

g/l

1.25

243

1687

(3051611) Lipemic interference index of Serum or Plasma

211

2.29

6.69

2.9

3.8

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.31

6.68

2.7

2.4

—

(3029937) Albumin [Presence] in Urine by Test strip

753

6305

1.26

6.58

4.4

3.9

0.0

estimate

1.08

279

1968

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

437

1.88

6.57

1.9

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

483

1.82

6.46

1.4

1.5

—

(3007461) Platelets [#/volume] in Blood

2815

27146

1.36

6.34

27.5

18.6

247.2

245.6

e9/l

0.58

2763

26323

(3004588) Protein electrophoresis panel - Serum or Plasma

230

1628

1.45

6.30

2.2

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

338

1.97

6.26

5.9

5.7

274.7

579.6

iu/ml

0.55

(3024731) MCV [Entitic volume]

2815

27154

1.36

6.25

27.4

18.5

91.1

91.2

0.34

2789

26673

(3026361) Erythrocytes [#/volume] in Blood

2815

27157

1.36

6.22

27.5

18.6

4.5

e12/l

5.24

2751

26232

(3010813) Leukocytes [#/volume] in Blood

2815

27161

1.36

6.18

27.6

18.6

7.0

6.7

e9/l

7.70

2751

26232

(3000963) Hemoglobin [Mass/volume] in Blood

2815

27163

1.36

6.16

27.7

18.7

135.0

137.4

g/l

13.30

2789

26682

(3017354) Segmented neutrophils/100 leukocytes in Blood

181

2.34

6.15

2.5

2.6

61.4

58.8

0.28

110

(3035941) MCH [Entitic mass]

2814

27154

1.36

6.14

27.4

18.5

30.3

30.4

2.96

2788

26675

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

2.74

6.11

3.8

4.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

253

1835

1.41

6.07

2.3

2.2

12.3

14.4

nmol/l

3.95

224

1631

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

302

2.01

5.99

1.4

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

223

1586

1.44

5.97

4.8

3.5

5.2

kpa

0.54

209

1451

(3021901) Oxygen saturation in Capillary blood

459

1.81

5.96

3.3

2.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

276

2.05

5.92

1.7

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2528

24078

1.26

5.92

5.0

4.7

6.0

mmol/l

0.21

2328

21918

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

210

2.21

5.91

2.2

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

400

3132

1.32

5.90

1.4

1.3

520.8

537.5

titre

0.08

659

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

213

1507

1.44

5.87

4.5

3.5

2.0

1.8

mmol/l

0.27

163

1087

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

272

2.04

5.77

2.1

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

593

1.69

5.70

1.2

43.0

84.8

titre

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

323

1.94

5.64

2.0

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.89

5.61

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.89

5.61

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

113

704

1.63

5.60

3.1

1.6

33.0

45.3

mg/l

0.73

568

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

110

681

1.64

5.59

2.9

1.5

2.1

3.1

ratio

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

175

1204

1.48

5.58

2.9

3.0

4.4

4.5

pmol/l

1.27

160

1048

(3009343) pH of Capillary blood

217

1558

1.42

5.53

4.7

3.6

7.4

1.28

188

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

263

2.03

5.53

1.5

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

595

1.67

5.39

2.2

2.0

9.7

11.2

mg/l

1.32

545

(40768806) Pleura Pathology biopsy report

174

2.26

5.32

1.4

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

281

1.97

5.31

1.4

1.2

—

nmol/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

666

5620

1.23

5.30

4.0

3.5

—

(3003694) ABO and Rh group [Type] in Blood

689

5858

1.23

5.08

1.4

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

111

707

1.59

5.06

3.1

1.6

46.7

48.9

mg/l

0.16

572

(3005322) IgE [Units/volume] in Serum or Plasma

199

1431

1.42

5.05

1.4

1.3

195.2

234.7

u/ml

0.38

185

1322

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

147

998

1.50

5.03

5.0

4.6

1.8

1.6

0.94

139

934

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

417

1.77

5.01

1.2

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

166

2.24

5.00

1.3

0.4

1.4

u/ml

0.79

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

655

1.61

4.98

1.2

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

577

4831

1.24

4.91

1.8

1166.9

1151.4

nmol/l

0.16

454

3651

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

103

651

1.60

4.86

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

104

659

1.60

4.86

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

235

2.02

4.85

1.3

284.9

278.7

mosm/kgh2o

0.91

177

(3014051) Protein [Presence] in Urine by Test strip

529

1.66

4.79

2.0

2.2

—

(44790048)

216

2.05

4.77

1.8

1.5

—

(44790049)

216

2.05

4.77

1.8

1.5

—

(44790047)

216

2.05

4.77

1.8

1.5

—

(44806118)

216

2.05

4.77

1.8

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

439

1.73

4.75

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

330

1.83

4.69

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

626

1.60

4.68

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

192

2.10

4.61

1.2

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

2.39

4.56

1.7

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

142

980

1.47

4.52

5.1

4.7

0.9

0.58

135

918

(3024928) Oxygen saturation in Venous blood

539

1.63

4.48

2.9

3.1

—

(3022313) Gas panel - Capillary blood

159

1128

1.43

4.39

5.0

3.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

137

2.28

4.38

2.1

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

856

1.49

4.35

2.5

1.4

10.1

10.5

g/l

0.55

107

718

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2416

23110

1.20

4.31

6.3

6.1

40.2

40.3

mmol/mol

0.24

2246

21405

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

2.54

4.29

2.2

1.8

3.3

6.7

nmol/l

0.67

(3045414) Leukocytes [Presence] in Urine

149

1049

1.44

4.29

1.8

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.96

4.28

1.8

1.3

—

(3036603) Volume of Urine

126

2.31

4.26

1.7

1.3

2172.4

1956.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

235

1791

1.34

4.21

4.0

3.9

94.6

93.9

ng/l

0.04

209

1528

(3015235) Bicarbonate [Moles/volume] in Capillary blood

100

651

1.55

4.21

4.1

3.1

25.1

25.0

mmol/l

0.11

571

(3023323) Follitropin [Units/volume] in Serum or Plasma

644

1.55

4.19

1.4

1.3

29.4

28.4

iu/l

0.11

551

(3011412) CD3 cells [#/volume] in Blood

140

2.23

4.18

2.5

1.9

1.1

1.2

e9/l

0.20

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

300

1.81

4.13

1.5

1.4

214.2

333.7

pmol/l

1.85

228

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

168

2.10

4.07

1.4

1.2

—

(3011985) Renin [Units/volume] in Plasma

318

1.77

4.00

1.6

1.3

47.8

97.6

mu/l

0.80

288

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

139

980

1.44

3.99

2.2

1.9

37.8

38.7

u/l

0.22

124

846

(3003327) Ova and parasites identified in Stool by Light microscopy

104

692

1.52

3.99

1.4

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

628

1.55

3.98

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

108

727

1.50

3.93

2.6

3.2

0.3

u/ml

0.05

419

(3041096) Erythrocytes [Presence] in Urine by Automated

705

6143

1.19

3.92

3.4

3.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

191

2.00

3.92

2.5

2.8

—

(3021960) Folate [Moles/volume] in Serum or Plasma

666

5778

1.19

3.89

1.6

1.5

19.7

20.3

nmol/l

0.55

594

4899

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

922

1.44

3.81

2.5

1.4

3.6

3.9

g/l

2.64

101

659

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

101

2.39

3.81

2.5

2.1

11.9

13.6

0.31

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

3.07

3.80

4.3

3.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

555

1.57

3.80

2.2

130.9

132.4

g/l

0.17

410

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

923

1.44

3.79

2.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

923

1.44

3.79

2.5

1.4

7.2

7.4

g/l

0.55

102

687

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

477

1.61

3.77

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

477

1.61

3.77

1.4

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

136

966

1.43

3.77

2.3

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

108

2.33

3.75

1.8

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

2.41

3.72

2.6

2.1

—

(3003181) Sodium [Moles/volume] in Urine

395

1.66

3.67

1.5

1.4

53.7

64.2

mmol/l

1.45

320

(3003338) MCHC [Mass/volume]

2169

20661

1.16

3.64

23.9

16.4

332.0

333.0

g/l

5.07

2159

20487

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.68

3.63

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

626

1.52

3.62

1.6

1.4

277.9

297.1

ug/g

0.43

371

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

123

867

1.44

3.57

2.6

1.4

3.0

g/l

0.26

101

674

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.45

3.54

1.4

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.45

3.54

1.4

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.45

3.54

1.4

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.45

3.54

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.31

3.51

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.31

3.51

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.31

3.51

1.2

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

456

3858

1.21

3.47

1.3

1.2

12.5

14.1

u/ml

0.16

143

1507

(3024354) Oxygen [Partial pressure] in Venous blood

242

1908

1.29

3.44

3.2

2.9

4.8

4.6

kpa

0.69

233

1834

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

242

1911

1.29

3.40

2.9

2.3

76.1

65.9

ml/min/173m2

1.06

109

729

(3024980) IgG subclass 4 [Mass/volume] in Serum

366

1.65

3.37

2.0

1.7

0.9

1.0

g/l

0.04

285

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.84

3.35

1.7

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

406

1.61

3.33

1.1

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

631

1.49

3.31

2.7

1.4

0.0

g/l

0.00

584

(4062490)

233

1.81

3.29

1.8

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

520

1.53

3.25

3.2

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

587

1.50

3.19

2.8

2.4

203.6

187.7

0.68

558

(3047189) Immunofixation for 24 hour Urine

2.36

3.15

1.5

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

508

1.53

3.14

3.5

2.8

34.8

36.2

umol/l

0.17

435

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

993

9028

1.15

3.11

4.3

3.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

474

4067

1.19

3.11

1.3

41.2

37.4

iu/ml

0.14

132

1241

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

219

1731

1.29

3.08

1.9

—

(40757373) Influenza virus identified in Isolate

2.81

3.08

2.7

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

276

1.71

3.06

1.1

0.4

3.6

u/ml

2.15

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.01

3.05

1.4

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

643

1.46

3.04

2.7

1.4

0.0

g/l

0.00

587

(21494890) Protein electrophoresis panel - 24 hour Urine

210

1.82

3.04

1.6

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

586

1.48

3.03

1.8

1.7

292.5

305.0

mu/l

0.17

536

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

123

897

1.39

3.00

2.3

1.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

233

1.77

3.00

1.8

1.4

3.3

3.0

g/l

0.46

168

(3024139) IgG subclass 3 [Mass/volume] in Serum

233

1.77

3.00

1.8

1.4

0.4

g/l

0.15

169

(3027135) IgG subclass 1 [Mass/volume] in Serum

233

1.77

3.00

1.8

1.4

6.8

g/l

0.02

170

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

547

1.49

2.98

1.1

—

(3022621) pH of Urine by Test strip

199

1561

1.29

2.98

2.9

3.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

161

1227

1.33

2.97

3.5

2.5

0.3

e6/l

0.07

155

1195

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

107

2.16

2.96

1.9

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

565

1.48

2.94

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

164

1256

1.32

2.93

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

339

2834

1.22

2.93

1.7

1.8

1.5

0.09

285

2487

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

206

1.81

2.90

1.2

55.1

58.6

u/l

0.16

136

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

198

1558

1.29

2.90

1.9

1.8

—

(44813793)

142

1.98

2.89

1.1

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1125

10358

1.13

2.87

5.0

3.7

2.7

2.3

ug/l

0.36

1002

9338

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

208

1.79

2.82

1.3

1.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

553

4849

1.17

2.81

1.3

1.1

2.0

u/ml

2.10

158

1305

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

688

1.42

2.80

2.7

1.4

0.1

0.0

g/l

0.68

631

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

748

6713

1.15

2.79

1.6

1.4

mmol/l

0.85

610

5650

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

102

731

1.41

2.78

2.6

1.4

38.2

37.8

g/l

0.23

613

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.92

2.77

1.2

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

5.01

2.72

2.3

3.0

8704.7

1381.1

u/l

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

526

1.48

2.71

1.2

1.4

9.9

8.4

u/l

0.41

431

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

292

2427

1.22

2.68

2.5

2.4

8.8

8.1

ug/l

0.10

262

2117

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

190

1.80

2.66

1.3

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

106

773

1.38

2.63

3.1

1.5

1.0

0.5

g/l

1.09

664

(3004716) Salmonella sp identified in Stool by Organism specific culture

137

1045

1.33

2.56

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

128

1.96

2.55

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

262

3140

0.82

2.48

4.9

4.8

31.8

32.4

0.42

196

2117

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

158

1.84

2.47

1.9

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

128

974

1.33

2.44

5.2

3.9

24.9

24.7

mmol/l

0.39

121

894

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

648

1.40

2.43

2.6

2.2

91.3

90.5

0.10

612

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

524

1.44

2.39

1.8

1.9

3.9

5.0

iu/l

0.39

168

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.34

2.39

1.3

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

339

1.54

2.32

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.05

2.31

2.2

2.5

867.9

862.8

u/ml

0.01

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

177

1.76

2.30

1.2

—

(4034850)

871

0.68

2.28

15.4

9.7

—

(4015189)

2.23

2.27

1.4

2.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.89

2.25

3.9

2.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

247

1.63

2.24

1.3

1.5

30.7

29.0

g/l

0.32

216

(3008536) Aspergillus sp Ab [Presence] in Serum

3.11

2.22

1.8

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

191

1554

1.24

2.19

3.3

3.0

126.3

131.7

g/l

2.63

186

1505

(3017732) Neutrophils [#/volume] in Blood

191

1556

1.24

2.17

3.6

3.1

4.2

4.1

e9/l

0.18

155

1164

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.29

2.15

1.0

1.1

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

149

1182

1.27

2.13

2.6

1.3

0.05

149

1173

(3029075) Extractable nuclear Ab panel - Serum

2.37

2.12

1.1

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.45

2.10

1.0

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.01

2.07

1.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

269

1.57

2.06

1.4

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

301

1.54

2.05

1.1

0.4

0.9

u/ml

1.16

128

(21494755) Public health laboratory ask at order entry panel

161

1986

0.80

2.04

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

491

1.41

2.04

3.2

3.0

0.8

nmol/l

0.07

363

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.11

2.02

1.1

2.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

193

1.66

1.99

1.1

0.2

0.3

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

647

1.35

1.99

1.4

1.5

1.2

g/l

0.46

608

(3003888) Timothy IgE Ab [Units/volume] in Serum

312

1.51

1.98

1.1

4.1

4.7

u/ml

0.13

159

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

264

1.56

1.97

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

119

1.85

1.97

1.6

467.2

782.1

e6/l

—

(3025941) Bacteria identified in Stool by Culture

151

1214

1.26

1.95

1.5

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

164

1.71

1.94

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

164

1.71

1.94

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

164

1.71

1.94

1.3

1.2

—

(3036489) Thrombin time

106

816

1.31

1.93

2.5

2.0

22.0

21.3

0.37

712

(21494434) Karyotype in Bone marrow

172

1.69

1.93

1.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

266

1.55

1.92

1.4

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

356

1.47

1.90

1.1

1.4

1.3

u/ml

0.03

144

(3021788) Differential panel - Synovial fluid

482

1.40

1.89

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

900

8353

1.11

1.86

4.5

3.6

22.8

24.0

1.47

419

3856

(40765096) Chromosome analysis panel by Banding

2.65

1.86

1.0

—

(3011288) Drugs identified in Urine by Screen method

391

1.44

1.86

3.2

3.1

—

(4212803)

3.53

1.83

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.53

1.83

2.2

2.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

302

1.50

1.82

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

160

1.69

1.81

1.2

1.3

526.1

290.6

u/l

0.47

152

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

632

1.34

1.81

1.4

1.6

0.2

g/l

0.20

598

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.05

1.80

1.4

1.9

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.03

1.75

2.6

1.3

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

—

18.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

—

35.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

348

1.44

1.71

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

180

1.62

1.66

1.1

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.16

1.66

1.2

1.0

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

127

1.74

1.64

1.0

9.1

14.1

iu/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

189

1.59

1.62

2.2

2.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2495

24396

1.11

1.62

4.6

1.4

mmol/l

5.02

2314

22470

(3015171) Extractable nuclear Ab [Units/volume] in Serum

113

901

1.26

1.62

1.3

1.2

0.3

1.1

u/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.58

1.61

1.2

1.5

—

(3011648) Oxygen content in Venous blood

198

1.57

1.59

2.4

2.3

11.8

11.3

0.20

198

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

198

1.57

1.59

4.2

2.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2512

24580

1.11

1.58

4.7

4.6

4.5

4.6

mmol/l

1.37

2350

22783

(1002224) Polysomnography panel

119

958

1.25

1.58

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.11

1.55

2.8

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

632

1.31

1.54

1.3

1.2

5.1

44.0

u/ml

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

192

1.57

1.54

1.3

1.2

115.0

113.6

titre

—

(3012441) Differential panel - Pleural fluid

192

1.57

1.54

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

257

1.48

1.53

1.4

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

468

1.35

1.52

1.3

1.2

1.1

7.3

u/ml

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.60

1.51

1.9

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

106

1317

0.80

1.50

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

573

1.32

1.50

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

258

1.48

1.50

1.4

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

242

1.49

1.1

4.2

4.0

u/ml

0.04

(3020650) Glucose [Presence] in Urine

2.07

1.49

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

226

1.51

1.49

1.4

1.5

2682.0

1743.7

e6/l

0.30

161

(3043409) Potassium [Moles/volume] in Arterial blood

751

1.27

1.48

3.7

4.2

3.8

3.9

mmol/l

0.93

704

(3005988) Vibrio sp identified in Specimen by Organism specific culture

259

1.47

1.48

1.4

1.2

—

(3035880) pH of Pleural fluid

1.81

1.47

1.1

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

301

1.43

1.46

1.3

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.12

1.44

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.12

1.44

2.3

2.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

125

1.68

1.43

1.6

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.31

1.43

1.1

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

270

1.45

1.41

3.2

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2413

23602

1.10

1.41

4.2

4.1

1.4

1.3

mmol/l

3.88

2217

21572

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.00

1.38

4.6

1.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

146

1222

1.20

1.37

3.9

3.0

25.7

25.2

mmol/l

1.02

141

1177

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

477

1.33

1.37

1.4

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.20

1.37

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

127

1.66

1.36

1.6

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

592

1.29

1.35

1.4

1.2

8.6

5.9

u/ml

0.24

101

(3020874) Milk IgE Ab [Units/volume] in Serum

1.76

1.34

1.0

1.1

1.5

2.8

u/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

199

1.51

1.34

1.4

1.5

27977.7

66023.3

e6/l

0.53

119

(3048929) Epstein Barr virus Ab [Presence] in Serum

577

1.29

1.31

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

1.74

1.31

3.2

2.3

31.6

44.7

—

(3028717) Thiamine [Mass/volume] in Blood

2.50

1.30

1.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

177

1.53

1.28

2.0

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

169

1970

0.85

1.28

1.7

1.8

—

(4133840)

1.94

1.27

1.5

1.1

—

(3045788) Cell count panel - Pleural fluid

178

1.52

1.26

1.6

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2552

25069

1.10

1.24

5.3

5.1

2.7

mmol/l

0.95

2370

23109

(3023430) Cat dander IgE Ab [Units/volume] in Serum

220

1.46

1.23

1.1

3.4

4.9

u/ml

0.36

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

442

1.32

1.23

1.3

1.2

52.4

45.7

u/ml

—

(3002619) Bacteria identified in Specimen by Culture

2.17

1.21

1.1

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

585

1.27

1.20

1.4

1.2

1.8

2.6

u/ml

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

392

1.33

1.19

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

629

5863

1.09

1.18

2.9

2.6

0.8

0.7

ug/l

0.54

415

3848

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

165

1.52

1.17

1.5

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

403

1.32

1.15

2.8

2.0

3659.2

2965.9

u/l

0.13

165

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.50

1.15

1.0

1.3

2.6

10.1

u/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.50

1.15

1.0

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

2.50

1.15

1.6

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

302

2715

1.12

1.15

1.4

—

(3037121) Protein [Mass/volume] in Urine

752

1.23

1.13

2.4

2.8

0.3

g/l

0.10

275

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

200

1752

1.15

1.13

1.4

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

270

0.63

1.12

1.2

1.9

—

1400.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

103

854

1.21

1.11

1.6

—

(3019977) pH of Arterial blood

135

1.56

1.11

3.7

2.3

7.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

109

910

1.20

1.10

2.3

2.4

769.9

707.7

ug/l

0.06

860

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

226

1.42

1.10

1.4

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.95

1.08

2.6

2.8

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

112

1.61

1.08

1.9

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.19

1.08

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

202

1.44

1.07

1.1

1.4

1.2

1.4

promille

0.19

155

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.93

1.06

2.0

1.5

—

(3019225) pH of Specimen

260

2331

1.13

1.05

5.0

3.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

366

1.32

1.05

1.1

1.2

212.1

255.2

u/ml

0.68

229

(3009508) Creatinine [Moles/volume] in Urine

880

8354

1.07

1.04

3.5

3.2

7.4

7.7

mmol/l

1.78

743

7050

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

157

1361

1.16

1.04

1.2

61.8

141.0

iu/ml

4.69

518

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

725

1.22

1.03

1.6

0.2

4.0

iu/ml

0.48

157

(3013293) Extractable nuclear Ab [Presence] in Serum

2.06

1.03

1.4

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.03

1.0

1.1

—

(3020891) Body temperature

119

1010

1.19

1.02

4.1

4.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

298

1.35

1.02

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

299

1.34

1.00

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

256

1.37

1.00

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

131

1.53

0.99

1.7

1.5

9.8

5.4

u/l

0.50

(3040151) Glucose [Moles/volume] in Capillary blood

291

1.34

0.99

6.9

9.1

7.1

7.4

mmol/l

0.35

243

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

361

1.31

0.99

1.4

110.6

109.6

u/ml

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

693

1.22

0.98

1.9

2.3

101.6

121.2

ug/min

0.23

425

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

168

1473

1.15

0.97

1.2

1.3

64.7

56.4

au/ml

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.95

0.97

1.0

1.1

105.2

53.1

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

132

1.52

0.97

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.80

0.96

2.2

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

149

1.48

0.95

2.5

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

742

1.21

0.94

1.6

1.8

—

(3016244) Insulin [Units/volume] in Serum or Plasma

125

1.52

0.94

3.2

33.1

20.7

mu/l

0.66

119

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

251

1.36

0.93

1.8

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

303

1.32

0.93

1.4

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.22

0.93

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

140

1216

1.16

0.93

3.7

3.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

143

0.56

0.93

1.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

143

0.56

0.93

1.0

1.3

—

(40761535) Cells panel - Urine sediment

229

2058

1.12

0.92

4.0

3.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.14

0.91

2.0

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

393

1.28

0.90

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.75

0.90

1.5

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.75

0.90

1.5

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

332

1.30

0.89

1.3

1.5

65.7

60.9

0.37

220

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

100

849

1.18

0.89

1.8

2.8

4.4

mg/l

0.96

586

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.91

0.88

1.3

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.79

0.87

2.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

838

7991

1.07

0.87

3.5

3.2

551.9

228.2

mg/l

1.03

570

5151

(3000093) Morphology [Interpretation] in Blood Narrative

212

1.37

0.86

1.3

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

406

1.26

0.85

1.4

—

(4024509)

227

0.66

0.84

1.2

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.59

0.84

4.6

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.59

0.84

1.3

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

182

1624

1.13

0.84

2.2

2.4

13.8

25.1

au/ml

—

(4281824)

121

1.49

0.82

1.3

1.2

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

125

1089

1.15

0.82

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.88

0.81

1.2

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

206

1.36

0.81

1.7

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

383

1.26

0.79

1.5

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.82

0.79

3.2

2.7

0.3

0.6

u/field

—

(3001729) Color of Synovial fluid

0.00

0.77

0.0

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.77

0.0

1.6

—

(44806071)

0.00

0.76

0.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.09

0.74

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.09

0.74

1.0

—

(3000012) Reticulocyte production index

116

1.47

0.74

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

116

1.47

0.74

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.50

0.72

2.8

2.5

89.7

97.6

0.35

(3028433) Virus identified in Specimen by Culture

1.58

0.71

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.92

0.70

1.4

—

(3017569) Oxygen content in Arterial blood

143

1.40

0.70

3.7

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1006

0.86

0.69

1.5

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

135

1.41

0.69

1.5

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.67

0.68

1.1

1.3

—

22.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

401

1.23

0.68

1.2

41.3

25.0

u/l

0.43

344

(3045424) Erythrocytes [Presence] in Urine

393

1.22

0.66

1.3

1.6

—

(36660697) Celiac disease serology panel - Serum

195

1778

1.10

0.65

1.1

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

483

0.81

0.65

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.57

0.65

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.48

0.64

1.8

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.48

0.64

1.8

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.73

0.64

1.0

1.2

1.7

1.8

umol/24h

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

258

0.73

0.63

1.1

1.3

337377.0

145576.3

e6/l

—

184

(1001926) Buprenorphine [Presence] in Urine by Screen method

478

1.20

0.63

3.7

2.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

112

1.43

0.63

1.3

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

129

1.40

0.63

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

102

0.59

0.62

1.3

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.63

0.62

1.7

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.59

0.61

1.6

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.60

0.61

1.3

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

174

1585

1.10

0.61

1.2

—

(4146454)

301

0.76

0.61

2.8

2.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

128.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

367

0.79

0.60

1.3

1.2

1.9

3.2

u/ml

—

119

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.54

0.59

7.1

7.5

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

0.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

209

0.72

0.59

1.1

1.0

686.0

709.9

ng/l

—

136

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

265

0.75

0.58

1.1

1.3

1.5

nmol/l

1.07

237

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.48

0.57

1.0

1.1

115.0

106.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

661

1.15

0.57

1.4

1.6

26287.2

13261.8

e6/l

0.89

482

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

292

1.24

0.56

2.0

2.3

15.3

22.8

mg/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

185

1.30

0.56

1.3

1.7

—

68.8

—

(3004451) EKG impression Narrative

125

1.36

0.53

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.54

0.53

1.7

2.1

14.0

18.5

umol/l

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

620

1.15

0.52

1.2

1.1

1.7

7.5

u/ml

1.95

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

359

0.81

0.52

1.2

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

870

8428

1.04

0.51

4.3

4.0

8.0

8.8

mg/mmol

0.26

586

5441

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

206

1.26

0.51

1.2

1.4

0.4

0.3

nmol/l

0.26

169

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.49

0.49

17.4

7.2

—

(3027008) Opiates [Presence] in Urine

614

1.14

0.49

3.3

2.1

—

(3016038) Potassium [Moles/volume] in Urine

154

1.30

0.48

1.6

1.3

28.9

35.9

mmol/l

0.73

138

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

166

0.72

0.47

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

739

1.13

0.47

1.3

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

155

1.29

0.46

2.8

2.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

664

1.13

0.46

1.9

1.7

—

(3028300) Cannabinoids [Presence] in Urine

617

1.14

0.46

3.4

2.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

182

1.27

0.46

1.0

1.1

—

titre

—

(3027944) Amphetamines [Presence] in Urine

608

1.14

0.46

3.4

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

609

1.14

0.45

3.4

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

827

1.12

0.45

2.1

1.8

—

(3048879) Bone marrow aspiration report

1.40

0.45

1.0

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

1.37

0.44

1.4

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.41

0.43

1.3

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.61

0.43

4.2

4.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.61

0.43

1.8

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

322

1.18

0.42

1.1

1.0

—

(3016879) Cocaine [Presence] in Urine

575

1.13

0.42

3.5

2.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.64

0.42

1.0

1.1

1108.7

1713.1

miu/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

122

1.31

0.42

1.5

1.9

—

11.8

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

131

1.30

0.42

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

595

0.87

0.42

1.7

1.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.63

0.42

2.8

2.6

139.5

161.1

nmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

140

1.29

0.42

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.52

0.41

3.2

10.0

6.0

mmol/l

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.41

0.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.47

0.40

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

132

1.29

0.40

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.43

0.39

6.0

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.43

0.39

3.0

2.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

421

0.85

0.39

1.0

1.1

6.3

88.5

iu/ml

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.35

0.38

2.7

1.7

133.1

155.0

0.45

(3044941) Cell count panel - Synovial fluid

439

1.14

0.37

1.5

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.32

0.37

1.1

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.32

0.37

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

107

1.31

0.37

1.1

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.35

0.37

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

116

0.69

0.37

2.0

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.39

0.37

1.3

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.39

0.37

1.3

2.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

223

0.81

0.35

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

144

1.25

0.35

1.0

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

604

1.11

0.34

2.1

1.9

218.6

204.2

pmol/l

0.52

572

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

182

1.21

0.33

1.1

1.3

11.1

12.2

mmol/l

0.34

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1.22

0.32

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1.22

0.32

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1.22

0.32

1.2

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

247

1.18

0.32

1.3

1.5

29.9

0.00

164

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.28

0.32

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

192

1.20

0.32

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

211

1.19

0.31

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.32

0.30

1.1

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

240

0.83

0.30

1.1

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

142

0.77

0.30

7.3

9.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

315

0.86

0.30

1.6

2.1

—

2.6

—

(3023410) Appearance of Cerebral spinal fluid

221

1.18

0.30

1.8

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

526

0.89

0.30

4.3

2.8

7.7

7.6

mmol/l

0.17

507

(3036071) Salmonella sp Ab [Titer] in Serum

1.33

0.30

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

111

1.26

0.30

3.0

3.5

—

(3025130) Human papilloma virus identified in Specimen

203

1.18

0.29

1.9

1.7

—

(3044927) Protein electrophoresis panel - Urine

281

0.85

0.29

1.1

—

(3017704) Immunofixation for Urine

130

1.23

0.28

1.8

1.2

—

(3019150) Specific gravity of Urine by Refractometry

550

5353

1.03

0.28

4.8

3.9

1.0

kg/l

1.35

788

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

259

0.85

0.28

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

259

0.85

0.28

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

259

0.85

0.28

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

216

0.83

0.28

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.32

0.28

17.4

7.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

272

2613

1.04

0.27

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

258

0.85

0.27

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

120

0.75

0.27

1.3

—

(3005033) Fetal Nuchal fold Thickness US

215

0.84

0.27

1.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

128

0.78

0.26

1.3

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

159

1.20

0.26

1.1

1.0

326.1

264.7

mg/l

0.52

138

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

104

1.25

0.26

1.3

1.2

—

12.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.19

0.26

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.19

0.26

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.19

0.26

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.19

0.26

1.1

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

310

1.13

0.26

1.3

8.0

7.6

mmol/l

0.23

227

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.25

0.25

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

123

1.22

0.25

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

181

0.83

0.25

1.7

2.0

3.0

3.3

ug/l

—

160

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

170

1.18

0.24

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

170

1.18

0.24

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

170

1.18

0.24

1.3

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.74

0.24

1.2

1.8

—

(3022689) Creatine [Moles/volume] in Urine

0.71

0.24

1.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

145

1378

1.05

0.24

1.5

1.6

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

124

1.21

0.24

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.32

0.23

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

476

1.09

0.23

1.6

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

190

1.16

0.23

2.0

1.4

1.0

g/l

0.11

190

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.28

0.23

1.0

1.1

88.0

73.6

ug/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.25

0.22

2.4

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.25

0.22

1.4

1.1

—

(3014271) Vancomycin [Susceptibility]

135

0.81

0.22

3.6

2.9

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

104

0.77

0.21

1.1

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3004775) Volume in Urine collected for unspecified duration

219

0.87

0.20

1.8

2.3

630.0

616.4

0.05

147

(3050129) First trimester maternal screen panel - Serum or Plasma

303

0.89

0.20

1.3

1.4

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.20

0.0

3.4

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.22

0.20

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

115

0.78

0.20

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

165

1.15

0.19

1.1

48.0

37.3

mg/l

0.31

135

(3035933) Granulocytes/100 leukocytes in Blood

1.15

0.19

1.0

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

280

0.89

0.18

1.3

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

132

0.83

0.18

1.1

7.0

—

58.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.15

0.17

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.13

0.17

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

556

0.93

0.16

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

266

0.90

0.15

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.79

0.15

1.3

1.4

8.7

9.0

ug/l

—

(4268621)

245

0.90

0.15

2.3

2.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.75

0.15

1.0

—

(3034426) Prothrombin time (PT)

1.21

0.15

1.2

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

359

0.92

0.15

1.4

1.2

2.2

5.9

u/ml

2.96

151

(4198724)

1.10

0.15

1.3

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

129

0.85

0.14

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

244

0.90

0.14

1.1

—

22.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

538

1.06

0.14

4.5

3.6

30.1

28.3

mg/l

0.14

353

(3016018) Differential panel - Cerebral spinal fluid

237

1.10

0.14

1.7

1.4

—

(4211845)

122

1.15

0.13

3.0

3.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.14

0.12

1.1

1.0

1.1

u/l

—

(3008898) HLA-B27 [Presence]

730

1.04

0.11

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

192

1.09

0.10

2.0

1.7

—

(3016750) Collection duration of Urine

156

0.90

0.10

1.6

2.0

496.3

489.9

min

—

116

(3052592) Norovirus Ag [Presence] in Stool

1.14

0.10

1.2

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.14

0.10

1.0

1.2

47.8

33.4

nmol/l

—

(3024869) Neuronal Ab [Presence] in Serum

1.11

0.09

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

408

1.05

0.09

2.3

3.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.09

0.09

1.4

—

(3044007) Cell count panel - Peritoneal fluid

1.06

0.09

3.8

2.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.06

0.09

1.4

1.8

184.0

150.9

ng/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

291

1.07

0.09

1.2

1.0

1.4

2.9

u/ml

1.70

126

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

204

1.08

0.08

1.9

2.1

4.3

1.9

u/field

0.80

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

216

0.93

0.08

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.83

0.08

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.08

0.08

1.1

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.08

0.08

1.1

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

123

0.89

0.08

1.8

1.3

134.7

144.4

nmol/l

0.43

123

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

328

3239

1.01

0.07

9.9

6.7

—

(44806420)

0.80

0.07

3.0

2.4

—

(3042733) HLA Ab [Presence] in Serum

1.04

0.07

4.0

5.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.88

0.06

1.3

1.2

—

(4027681)

128

1.09

0.06

1.4

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

102

0.88

0.06

1.3

1.7

10.0

9.9

ug/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

608

0.97

0.06

5.3

4.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

554

1.03

0.05

1.3

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

222

0.95

0.05

1.4

1.5

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

110

0.91

0.05

15.9

11.0

0.6

mmol/l

—

102

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

515

1.03

0.05

1.5

1.2

227.7

220.9

miu/ml

0.04

223

(3033705) Calcium.ionized [Moles/volume] in Venous blood

298

1.04

0.04

2.6

2.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

526

1.03

0.04

1.5

1.3

22.9

22.8

e6/l

0.00

415

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

526

1.03

0.04

1.6

1.4

13829.5

820.6

e6/l

0.56

438

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

139

0.93

0.03

17.8

12.4

888.8

816.4

nmol/l

0.22

131

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

548

1.02

0.03

1.2

1.8

1.1

0.8

nmol/l

1.21

453

(4094501)

747

1.02

0.03

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

779

1.01

0.02

1.8

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

1.05

0.01

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

1.05

0.00

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

464

1.01

0.00

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

105

1.05

0.00

1.4

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

165

0.97

0.00

1.3

1.4

—

87.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

359

1.00

0.00

1.1

1.3

—

(3024263) Appearance of Synovial fluid

156

1.03

0.00

1.4

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

539

5385

1.00

0.00

1.8

1.7

52232572.0

31994132.8

pmol/l

0.28

448

4454

(1761868) Lipid panel - Serum or Plasma

846

8462

1.00

0.00

2.9

3.0

—

(4306422)

357

1.01

0.00

1.4

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.02

0.00

1.2

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

15.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.5

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.96

0.00

1.1

1.0

—

(3024932) HLA-DR beta [Type]

0.97

0.00

1.3

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

9.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

0.89

0.00

1.9

1.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

7.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.00

0.00

1.2

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

230

1.00

0.00

1.6

1.4

100.6

202.2

pmol/l

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

39.0

—

(4038314)

0.00

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.94

0.00

1.0

2.1

1.2

mmol/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.00

0.0

1.0

—

6.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.96

0.00

1.3

1.2

119.7

112.9

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.4

—

4.3

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40768446) Kidney Pathology biopsy report

0.99

0.00

1.8

1.6

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_EAR_RESP_EXALLC – Benign neoplasm of middle ear and respiratory system

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm of middle ear and respiratory system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints